The former head of a now defunct pharmacy chain has died, according to published reports.

A pill developed by AstraZeneca and Pozen that combines a nonsteroidal anti-inflammatory drug with a proton-pump inhibitor was well-tolerated in patients with osteoarthritis, according to a new study.

Almost two-thirds of consumers live within 3 miles of a Walgreens. For the rest of America, Walgreens is using its multichannel strategy to get even closer. The deal with Drugstore.com considerably accelerates the chain's plans.

The Food and Drug Administration has approved a generic treatment for shingles and genital herpes made by Actavis, the drug maker said Wednesday.

Bristol-Myers Squibb said its late-stage clinical trial for a cancer treatment, which currently is under review by the Food and Drug Administration, achieved its primary endpoint.

Carex has introduced its Ultra Grip bath suction handle, the brand's first and only product with suction power.

Duane Reade, which is owned by Walgreens, has extended its contract with DeVito/Verdi, the New York ad agency that assisted with its marketing metamorphosis.

The Food and Drug Administration has extended its regulatory review period for Novartis' new drug application for its once-daily, long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, as well as chronic bronchitis and/or emphysema, the drug maker said.

Four-in-5 menthol smokers would quit if the Food and Drug Administration banned mentholated cigarettes, according to a survey conducted this month with sponsorship from GlaxoSmithKline Consumer Healthcare.

The Food and Drug Administration has approved a topical pain treatment made by Hi-Tech Pharmacal, the drug maker said Thursday.

In a letter to the Centers for Medicare and Medicaid Services, the National Community Pharmacists Association and 20 healthcare groups expressed their concerns over the proposed Medicare Part D long-term care “short cycle” rule.